GE

267.65

-0.8%↓

RTX

153.98

-0.79%↓

CAT

407.57

-2.39%↓

GEV.US

620.5

-0.62%↓

BA

235.54

+0.88%↑

GE

267.65

-0.8%↓

RTX

153.98

-0.79%↓

CAT

407.57

-2.39%↓

GEV.US

620.5

-0.62%↓

BA

235.54

+0.88%↑

GE

267.65

-0.8%↓

RTX

153.98

-0.79%↓

CAT

407.57

-2.39%↓

GEV.US

620.5

-0.62%↓

BA

235.54

+0.88%↑

GE

267.65

-0.8%↓

RTX

153.98

-0.79%↓

CAT

407.57

-2.39%↓

GEV.US

620.5

-0.62%↓

BA

235.54

+0.88%↑

GE

267.65

-0.8%↓

RTX

153.98

-0.79%↓

CAT

407.57

-2.39%↓

GEV.US

620.5

-0.62%↓

BA

235.54

+0.88%↑

Enovis Corp

Затворен

СекторИндустриални

29.55 2.32

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

29.43

Максимум

29.66

Ключови измерители

By Trading Economics

Приходи

19M

-37M

Продажби

-459M

100M

Марж на печалбата

-36.642

Служители

7,367

EBITDA

-208M

-184M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+67.72% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

86M

1.6B

Предишно отваряне

27.23

Предишно затваряне

29.55

Настроения в новините

By Acuity

50%

50%

198 / 460 Класиране в Industrials

Enovis Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

7.01.2025 г., 23:28 ч. UTC

Значими двигатели на пазара

Maplebear Up on S&P MidCap 400 Inclusion

Сравнение с други в отрасъла

Ценова промяна

Enovis Corp Прогноза

Ценова цел

By TipRanks

67.72% нагоре

12-месечна прогноза

Среден 49.56 USD  67.72%

Висок 75 USD

Нисък 29 USD

Според 10 анализатори от Wall Street, предложили 12-месечна ценова цел за Enovis Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

10 ratings

8

Купи

2

Задържане

0

Продай

Настроение

By Acuity

198 / 460 Класиране в Индустриални

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Среден

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Enovis Corp

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.